MaxCyte, Inc.
MXCT
$1.52
-$0.05-3.19%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.42M | -12.36M | -10.26M | -10.60M | -11.56M |
| Total Depreciation and Amortization | 1.27M | 1.29M | 1.28M | 1.53M | 1.19M |
| Total Amortization of Deferred Charges | 7.00K | 12.00K | -- | -- | -- |
| Total Other Non-Cash Items | 1.78M | 2.99M | 2.27M | 2.96M | 2.80M |
| Change in Net Operating Assets | 1.89M | -1.79M | -7.69M | -1.71M | 3.19M |
| Cash from Operations | -7.46M | -9.85M | -14.41M | -7.82M | -4.39M |
| Capital Expenditure | -300.00K | -584.00K | -653.00K | -147.00K | -406.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | -1.77M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.49M | 2.12M | 11.96M | -1.52M | 4.01M |
| Cash from Investing | 5.19M | 1.54M | 9.53M | -1.67M | 3.61M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 14.00K | 154.00K | 383.00K | 412.00K | 228.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 14.00K | 154.00K | 383.00K | 412.00K | 228.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.25M | -8.16M | -4.50M | -9.07M | -555.00K |